Publication Name	World Journal of Gastroenterology
Manuscript ID	90174
Country	United Kingdom

Received	2023-11-26 01:15
Peer-Review Started	2023-11-26 01:16
To Make the First Decision
Return for Revision	2023-12-25 05:25
Revised	2023-12-28 00:54
Second Decision	2024-02-05 02:42
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-02-05 05:04
Articles in Press	2024-02-05 05:04
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-02-26 05:48
Publish the Manuscript Online	2024-03-06 06:10

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Systematic Reviews
Article Title	Treatment of Helicobacter pylori with potassium competitive acid blockers: A systematic review and meta-analysis
Manuscript Source	Invited Manuscript
All Author List	Joseph Edwin Kanu and Jonathan Soldera
Funding Agency and Grant Number
Corresponding Author	Jonathan Soldera, MD, PhD, Instructor, Post Graduate Program at Acute Medicine and Gastroenterology, University of South Wales, Llantwit Rd, Pontypridd, Cardiff CF37 1DL, United Kingdom. jonathansoldera@gmail.com
Key Words	Helicobacter pylori infection; Potassium competitive acid blockers; Proton pump inhibitors; Vonoprazan; Amoxicillin
Core Tip	In the systematic review and meta-analysis on the treatment of Helicobacter pylori with potassium competitive acid blockers (P-CABs), vonoprazan-based triple therapy demonstrated superior efficacy over conventional proton pump inhibitor (PPI)-based triple therapy, establishing itself as a highly effective first-line regimen. Conversely, tegoprazan-based triple therapy was found to be non-inferior to classical PPI triple therapy. These findings signify a potential paradigm shift in H. pylori eradication strategies.
Publish Date	2024-03-06 06:10
Citation	Kanu JE, Soldera J. Treatment of Helicobacter pylori with potassium competitive acid blockers: A systematic review and meta-analysis. World J Gastroenterol 2024; 30(9): 1213-1223
URL	https://www.wjgnet.com/1007-9327/full/v30/i9/1213.htm
DOI	https://dx.doi.org/10.3748/wjg.v30.i9.1213

Full Article (PDF)	WJG-30-1213-with-cover.pdf
PRISMA 2009 Checklist	90174-PRISMA 2009 Checklist.pdf
Manuscript File	90174_Auto_Edited-YJP.docx
Answering Reviewers	90174-Answering reviewers.pdf
Audio Core Tip	90174-Audio core tip.ogg
Biostatistics Review Certificate	90174-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	90174-Conflict-of-interest statement.pdf
Copyright License Agreement	90174-Copyright license agreement.pdf
Peer-review Report	90174-Peer-review(s).pdf
Scientific Misconduct Check	90174-Bing-Wang JJ-2.png
Scientific Editor Work List	90174-Scientific editor work list.pdf